Recently, bacteriophage vectors have been developed for targeted gene delivery of antiangiogenic VTAs.Phage VectorsPhage display represents a novel method of individually displaying up to tens of billions of peptides, proteins, including human antibodies and enzymes, on the surface of a small bacterial virus called a phage.